Instituto do Cancer de Sao Paulo - ICESP

São Paulo, São Paulo 01246-000

0 studies enrolling now · 2 studies all time

What they study most

Endometrial Neoplasms, Renal Cell Carcinoma (RCC)

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed